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TO THE EDITOR
Psoriasis is generally considered to be
an immunologically initiated disorder,
which shares certain common suscept-
ibility loci with autoimmune diseases
(Zhang, 2012). Yet, both clinical
experience (Gottlieb et al.,1990;
Griffiths et al., 1995; Volden et al.,
2001) and recent molecular studies
(Mischke et al., 1996; Kim et al., 2011;
Vermeij et al., 2011; Bergboer et al.,
2012) support an emerging concept
that psoriasis could be ‘‘driven’’ by
a primary defect in epidermal permea-
bility barrier function. Clinicians know
well that psoriasis predictably flares
during winter months (Park and Youn,
1998; Kwon et al., 2012) when the
barrier is under additional stress owing
to low stratum corneum (SC) hydration,
which accelerates transepidermal water
loss (TEWL) rates (Lin, 2009;
Muizzuddin et al., 2013). They also
appreciate that sites vulnerable to
epidermal trauma, such as the exten-
sors of the extremities and the scalp,
are preferentially involved in psoriasis.
The Koebner phenomenon offers an
additional, eloquent example of
how psoriasis can be provoked by
external perturbations. Finally, improve-
ment of epidermal permeability barrier
function by occlusion alone often
alleviates psoriasis (e.g., Friedman,
1987).
Among psoriasis susceptibility genes,
PSORS4 is located on chromosome
1q21, within the epidermal differentia-
tion complex, which encodes numerous
proteins required for epidermal differen-
tiation and formation of the cornified
envelope (Mischke et al., 1996), a
structure that is critical for the
permeability barrier (Vermeij et al.,
2011). In addition, deletion of differen-
tiation-related proteins, such as keratin1,
whose levels are reduced in psoriasis
(Thewes et al., 1991; Bata-Cso¨rgo¨ and
Szell, 2012), not only compromises the
permeability barrier but also leads to
upregulation of inflammatory genes and
altered cytokine production in a pattern
that resembles psoriasis (Roth et al.,
2012). Finally, in experimental models,
disruption of the epidermal permeability
barrier in otherwise normal skin
stimulates epidermal hyperproliferation
(Proksch et al., 1991; Man et al., 2008),
cytokine production (Denda et al.,
1996; Wood et al., 1996), downstream
inflammatory cell infiltration (Proksch
et al., 1996; Lin et al., 2013), and
epidermal vascular endothelial growth
factor production, leading to dermal
capillary proliferation (Elias et al.,
2008), all of which are prominent
features of psoriasis.
Although prior studies have demon-
strated phenotype-dependent abnor-
malities in basal permeability barrier
function in psoriatic lesions (Ghadially
et al., 1996), the uninvolved skin in
psoriasis reportedly displays normal
TEWL levels (Takahashi et al., 2014).
Yet, expression levels of filaggrin, a
protein of known importance for the
barrier (Scharschmidt et al., 2009;
Irvine et al., 2011), and loricrin are
reportedly lower than normal in
uninvolved skin sites of psoriasis (Kim
et al., 2011). Because alterations in
the epidermal differentiation should
predict an abnormality in barrier
function, we hypothesized that if
abnormal epidermal function has a
role in the pathogenesis of psoriasis
then epidermal function should
be abnormal in uninvolved psoriatic
skin. Hence, we assessed changes in
epidermal function in the uninvolved
and involved skin of a large cohort of
Chinese patients, with either stable or
progressive psoriasis.
In all, 44 patients with psoriasis
vulgaris and 68 normal controls were
enrolled in the study (Table 1). All parti-
cipants were provided written informed
consent. This study was carried out
according to the Helsinki Declaration
Principles and the protocol approved by
the Human Research Subcommittee,
Dalian Skin Disease Hospital. Stable
psoriasis was defined as no recent
development of new lesions, as well as
no recent expansion of pre-existing
lesions, whereas progressive psoriasis
was defined as recent or ongoing devel-
opment of new lesions and prominent
inflammation, often accompanied byAccepted article preview online 29 April 2014; published online 5 June 2014
Abbreviations: SC, stratum corneum; TEWL, transepidermal water loss
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pruritus. None of the psoriatic patients
had other skin or systemic disorders,
and controls had no history of psoriasis,
other skin disorders, or systemic condi-
tions that could affect SC biophysical
properties. No topical medications were
used by patients forX1 week prior to
study; no skin care products were
applied to measured sites forX24 hours
prior to measurements; and measured
sites were not washed with either
soaps or surfactants forX2 hours prior
to study.
Epidermal functions were evaluated
in psoriatic lesions on the extensor
forearms and contralateral, uninvolved
skin sites, and comparable sites in nor-
mal controls. TEWL and SC hydration
were assessed using probes (TM300 for
TEWL and CM825 for hydration, respec-
tively) connected to a MPA5 (C&K,
Cologne, Germany). A pH900 pH meter
with a flat surface electrode (C&K) was
used to measure skin surface pH. For
assessment of barrier recovery kinetics,
TEWL was measured both immediately
(0 hours) and at 3 hours after six sequen-
tial D-Squame applications, and percent
barrier recovery was then calculated. All
subjects rested at 20–24 1C, at a relative
humidity of 50–55%, for at least 30 min-
utes before measurements were taken.
As psoriasis often flares during late
autumn and winter through early spring,
all studies were performed during
February and March 2012 and during
October 2013, representing early spring
and autumn seasons in northern China.
Consistent with prior findings
(Ghadially et al., 1996), our results
showed that both stable and progres-
sive psoriatic lesions displayed signifi-
cantly higher basal levels of TEWL than
the uninvolved skin and the skin sites of
normal control subjects (Figure 1a). Bar-
rier recovery was also delayed in the
involved skin of both progressive and
stable psoriasis (Figure 1b). Although
basal TEWL readings in uninvolved sites
of both stable and progressive disease
were comparable to those in normal
skin, barrier recovery kinetics were sig-
nificantly delayed in the uninvolved
skin sites of patients with progressive
psoriasis (Figure 1b).
Previous studies have demonstrated
that elevations in SC pH influence per-
meability barrier homeostasis (Mauro
et al., 1998; Hachem et al., 2005),
and, conversely, that barrier disruption
increases SC pH (Man et al., 2009).
Hence, we next measured changes in
surface pH in normal and psoriatic
patients. As seen in Figure 1c, the sur-
face pH of both involved and unin-
volved skin sites in progressive
psoriasis patients was significantly
higher than that in normal controls
(Po0.001); an apparent elevation in
SC pH was also observed in stable
psoriatic lesions, although the results
did not achieve statistical significance.
In contrast, the uninvolved skin of stable
psoriasis displayed normal surface pH
(Figure 1c).
Because SC hydration is a critical
regulator of epidermal proliferation and
cutaneous inflammation (Denda et al.,
1998; Denda, 2000), we next assessed
SC hydration in involved and uninvolved
psoriatic skin sites. SC hydration
markedly declined in involved skin of
both progressive and stable psoriasis,
but hydration levels were normal in
uninvolved skin sites of both psoriatic
cohorts (Figure 1d).
Recently, the central role of epider-
mal permeability barrier abnormalities
in the pathogenesis of inflammatory
dermatoses has attracted increased
attention. Previous studies have shown
that a sustained defect in permeability
barrier function predisposes skin to the
development of epidermal hyperplasia
and inflammation, resulting in part from
the stimulation of a cytokine cascade
that recruits a downstream inflammatory
cell infiltration (Proksch et al., 1996;
Elias et al., 1999; Elias and Wakefield,
2011). Because not only the involved
but also the uninvolved skin sites of
patients with progressive disease display
altered epidermal function, the results
presented here are consistent with an
emerging concept that an underlying
abnormality in epidermal function
initiates, triggers, or exacerbates psoriasis,
together supporting an ‘‘outside-to-
inside’’ concept of psoriasis pathoge-
nesis (Elias et al., 1999). The fact that
stable uninvolved psoriatic skin sites do
not display a demonstrable defect in
epidermal function can be explained
by the reestablishment of a steady
state, in which epidermal function has
largely been normalized, coupled with
reduced exposure to external stressors
that otherwise place additional stress on
the barrier. Nonetheless, it should be
noted that the uninvolved skin of
psoriasis could still display subtle abnor-
malities that are not detectable by the
biophysical technique utilized here. For
example, we have shown accelerated
movement of the water-soluble, electron-
dense tracer, lanthanum nitrate, in some
situations where TEWL levels otherwise
appeared normal (e.g., Scharschmidt
et al., 2009).
A defective permeability barrier not
only stimulates epidermal proliferation
(Proksch et al., 1991) but also increases
pro-inflammatory cytokine expression,
as well as increasing Langerhans cell
and mast cell infiltration (Nickoloff and
Naidu 1994; Proksch et al., 1996; Wood
et al., 1992, 1996; Lin et al., 2013).
Moreover, the abnormalities in surface
pH in the uninvolved skin of progressive
psoriasis could further predispose to
disease expression in psoriasis as
follows (Supplementary Figure S1
Table 1. Characteristics of subjects
Stage Gender n Mean age±SEM (years)
Psoriasis
Stable Male 15 33.07±2.63
Female 10 38.60±2.72
Progressive Male 10 36.20±2.80
Female 9 36.33±2.44
Control
Normal Male 34 39.15±0.96
Female 34 38.47±1.36
Total 112
L Ye et al.
Abnormal Epidermal Function in Psoriatic Skin
2844 Journal of Investigative Dermatology (2014), Volume 134
online): an elevation in pH inevitably
activates serine proteases (kallikreins) in
the outer epidermis that in turn degrade
lipid processing enzymes, leading to
abnormal permeability barrier homeos-
tasis (Hachem et al., 2005), and
catalyze pro-IL-1 beta to active IL-1
beta (Nylander-Lundqvist and Egelrud,
1997), initiating the cytokine cascade.
Finally, reduced SC hydration, which
often parallels abnormalities in barrier
function, alone places further stress
on the barrier as evidenced by the
development of epidermal proliferation
and the initiation of cutaneous inflam-
mation in experimental animals exposed
to low ambient humidity (Denda, 2000;
Ashida et al., 2001; Ashida and Denda,
2003). Coupling the present with prior
findings, we hypothesize that psoriasis
is characterized by a failure to com-
plete barrier repair owing to primary
abnormalities in epidermal structural
proteins, analogous to atopic derma-
titis, and is further aggravated by
exogenous stress to barrier (Supplemen-
tary Figure S1 online). Our findings
further suggest that approaches that
normalize barrier function could prove
valuable for the prevention and/or treat-
ment of psoriasis.
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Figure 1. Comparison of stratum corneum (SC) biophysical properties among normal, involved,
and uninvolved psoriatic skin sites. (a, b) Depict basal TEWL and barrier recovery rates, respectively. (c, d)
Present skin surface pH and SC hydration, respectively. Results are expressed as mean±SEM in
comparison with normal skin, as shown by the horizontal dotted lines. GraphPad Prism 4 software
(GraphPad Software, La Jolla, CA) was used for all statistical analysis. Dunnett’s multiple-comparison test
was used to determine the difference between normal and psoriasis-involved and -uninvolved skin, except
in Figure 1b in which the differences between normal and progressive uninvolved skin were determined
with the unpaired t-test. Po0.05 was considered to be a statistically significant difference. Significant
differences are shown in the figures, and the numbers of subjects are detailed in Table 1. Progressive in,
progressive involved; Progressive unin, progressive uninvolved; Stable in, stable involved; Stable unin,
stable uninvolved; TEWL, transepidermal water loss.
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TO THE EDITOR
There is increasing evidence that micro-
RNAs (miRNAs), small noncoding RNAs,
are involved in regulating melanogen-
esis. Various proteins, including TYR,
DCT, MELANA, and TYRP1, whose
mRNAs are potentially targeted by miR-
NAs orchestrate this process. miRNAs
regulate gene expression: in general,
they inhibit protein synthesis either by
repressing translation or by destabilizing/
degrading mRNAs by imperfect base
pairing to the ‘‘seed match’’ region in
the 50UTR, CDS, or 30UTR of the mRNAAccepted article preview online 26 May 2014; published online 26 June 2014
Abbreviations: MITF, microphthalmia-associated transcription factor; mRNA, microRNA; NHEM, normal
human epidermal melanocyte
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